GeneFerm Biotechnology Co., Ltd. (TPEX:1796)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
44.85
+0.05 (0.11%)
Jan 22, 2026, 1:30 PM CST
7.17%
Market Cap1.86B
Revenue (ttm)654.88M
Net Income (ttm)16.07M
Shares Out41.46M
EPS (ttm)0.39
PE Ratio115.56
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume28,230
Average Volume25,448
Open44.70
Previous Close44.80
Day's Range44.70 - 45.70
52-Week Range39.20 - 67.10
Beta-0.16
RSI35.57
Earnings DateMar 13, 2026

About GeneFerm Biotechnology

GeneFerm Biotechnology Co., Ltd. develops, manufactures, and sells fermented health products in Taiwan and internationally. The company offers microbial fermentation products, including fungi, bacteria, lactic acid bacteria, yeast, algae, etc.; bio fermented ingredients, such as nattomena, natto fermented powder, red yeast rice fermented powder, antrodia cinnamomea mycelia powder, cordyceps, reishi mycelia, phellinus linteus mycelia powder, armillaria mellea mycelia powder, beta-glucan powder, and fruits and vegetables fermented enzyme, as well... [Read more]

Sector Healthcare
Founded 1999
Employees 144
Stock Exchange Taipei Exchange
Ticker Symbol 1796
Full Company Profile

Financial Performance

Financial Statements